Aberdeen Group’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.4M | Sell |
42,556
-21,553
| -34% | -$6.76M | 0.02% | 531 |
|
|
2025
Q1 | $19.5M | Sell |
64,109
-745
| -1% | -$227K | 0.04% | 393 |
|
|
2024
Q4 | $21.5M | Sell |
64,854
-18,597
| -22% | -$6.18M | 0.04% | 351 |
|
|
2024
Q3 | $27.9M | Sell |
83,451
-3,684
| -4% | -$1.23M | 0.05% | 315 |
|
|
2024
Q2 | $35.9M | Sell |
87,135
-396
| -0.5% | -$163K | 0.07% | 264 |
|
|
2024
Q1 | $35.4M | Buy |
87,531
+70,048
| +401% | +$28.3M | 0.07% | 264 |
|
|
2023
Q4 | $5.36M | Buy |
+17,483
| New | +$5.36M | 0.01% | 656 |
|
|
2022
Q2 | – | Sell |
-8,000
| Closed | -$1.31M | – | 969 |
|
|
2022
Q1 | $1.31M | Sell |
8,000
-83
| -1% | -$13.6K | ﹤0.01% | 792 |
|
|
2021
Q4 | $1.76M | Sell |
8,083
-247,203
| -97% | -$53.8M | ﹤0.01% | 800 |
|
|
2021
Q3 | $48.3M | Sell |
255,286
-25,105
| -9% | -$4.75M | 0.11% | 191 |
|
|
2021
Q2 | $49.6M | Sell |
280,391
-99,993
| -26% | -$17.7M | 0.11% | 185 |
|
|
2021
Q1 | $62.4M | Buy |
380,384
+188,906
| +99% | +$31M | 0.14% | 151 |
|
|
2020
Q4 | $26.7M | Buy |
+191,478
| New | +$26.7M | 0.07% | 261 |
|